Arkolith/Insider Trading/CORT/Form 4

Mokari Atabak

Chief Financial OfficerCORCEPT THERAPEUTICS INC (CORT) · full profile →Form 4 · filed Jul 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.5M
Net Open-Market Flow
-$3.5M
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 15, 2026Option exercise(M)16K$19.26$305K32K
Jul 15, 2026Option exercise(M)24K$23.06$557K56K
Jul 15, 2026Sell(S)8K$86.78$687K48K
Jul 15, 2026Sell(S)28K$87.89$2.5M20K
Jul 15, 2026Sell(S)4K$88.30$311K16K
Jul 15, 2026Sell(S)101$89.43$9K16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 15, 2026Option exercise(M)16K—$04K
Jul 15, 2026Option exercise(M)24K—$0176K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-308058) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML